Bulletin
Investor Alert

New York Markets Close in:

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Market open

 --Real time quotes

Nov 29, 2021, 12:57 p.m.

/zigman2/quotes/205619834/composite

$

363.71

Change

+34.08 +10.34%

Volume

Volume 21.43m

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 329.63

$ 363.71

Change

+34.08 +10.34%

Day low

Day high

$350.27

$376.65

Open

52 week low

52 week high

$102.66

$497.49

Open

Annual Financials for Moderna Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 108.4M205.83M135.07M60.21M803.4M
Cost of Goods Sold (COGS) incl. D&A 15.11M20.54M24.86M31.02M39.18M
COGS excluding D&A ----7.93M
Depreciation & Amortization Expense 15.11M20.54M24.86M31.02M31.25M
Depreciation 15.11M20.54M24.86M31.02M31.25M
Amortization of Intangibles -----
Gross Income 93.28M185.29M110.21M29.19M764.21M
20162017201820192020 5-year trend
SG&A Expense 317.05M454.64M579.07M574.91M1.53B
Research & Development 274.72M410.46M509.68M465.29M1.34B
Other SG&A 42.34M44.19M69.39M109.62M188.27M
Other Operating Expense -----
Unusual Expense ----1.6M
EBIT after Unusual Expense ----(764.74M)
Non Operating Income/Expense (2.71M)(1.74M)4.93M(914,000)5.4M
Non-Operating Interest Income 11.31M15.24M27.02M38.53M24.72M
Equity in Affiliates (Pretax) -----
Interest Expense -132,0003.1M6.61M9.89M
Gross Interest Expense -132,0003.1M6.61M9.89M
Interest Capitalized -----
Pretax Income (215.17M)(256M)(440.01M)(514.72M)(744.51M)
Income Tax 1.04M(80,000)(55.27M)(695,000)2.55M
Income Tax - Current Domestic 755,000(80,000)326,000505,00032,000
Income Tax - Current Foreign ----2.52M
Income Tax - Deferred Domestic 288,000--(1.2M)-
Income Tax - Deferred Foreign -----
Income Tax Credits --55.6M--
Equity in Affiliates -----
Other After Tax Income (Expense) --(4.13M)--
Consolidated Net Income (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Minority Interest Expense -----
Net Income (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Preferred Dividends 14.1M13.93M13M--
Net Income Available to Common (230.31M)(269.84M)(401.86M)(514.02M)(747.06M)
EPS (Basic) (0.69)(1.92)(4.95)(1.55)(1.96)
Basic Shares Outstanding 332.89M140.6M81.11M330.8M381.33M
EPS (Diluted) (0.69)(1.92)(4.95)(1.55)(1.96)
Diluted Shares Outstanding 332.89M140.6M81.11M330.8M381.33M
EBITDA (208.66M)(248.82M)(444M)(514.7M)(731.89M)
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.